CLOs on the Move

Community Health Center of Snohomish County

www.chcsno.org

 
Community Health Center of Snohomish County (CHC) is a non-profit, Federally Qualified Community Health Center providing medical, dental, pharmacy, behavioral health, and additional ancillary services to nearly 70,000 individuals with 243,049 visits in 2021. For over 35 years, CHC has provided services to Snohomish County residents who face barriers to health care with the mission to provide our diverse community with access to high-quality, affordable primary health care. CHC operates seven medical primary care clinics, two medical walk-in clinics, six dental clinics, and five pharmacies, located in convenient locations in Arlington, Edmonds, Everett, and Lynnwood.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.chcsno.org
  • 8609 Evergreen Way
    Everett, WA USA 98208
  • Phone: 425.789.3700

Executives

Name Title Contact Details

Similar Companies

Hopedale Medical Complex

Hopedale Medical Complex is a Hopedale, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carman Oaks

Carman Oaks is a Lake Oswego, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TherOx

TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.

MONQ

Wherever you are, exhale Therapeutic Air® to immediately access the ancient wellness art of aromatherapy. Unlike topical oils or household diffusers, MONQ® is enhanced for convenience in the modern age. Experience the most direct form of aromatherapy with MONQ Personal Diffuser.

Clearway Health

Clearway Health partners with hospitals and health systems to build or strengthen their own specialty pharmacy program, improve access to care and provide personalized support to vulnerable patients, families, providers and care managers to eliminate b...